Verve Therapeutics Cash from Financing (TTM) Analysis

Verve Therapeutics Inc (VERV)

6.235 -0.34 (-5.24%) USD | NASDAQ | Apr 25, 16:00

6.235 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	212.58M
September 30, 2023	74.79M
June 30, 2023	331.28M
March 31, 2023	330.49M
December 31, 2022	328.96M
September 30, 2022	290.58M
June 30, 2022	1.307M

Date	Value
March 31, 2022	283.76M
December 31, 2021	377.09M
September 30, 2021	375.87M
June 30, 2021	376.74M
March 31, 2021	156.73M
December 31, 2020	92.63M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

1.307M

Minimum

Jun 2022

377.09M

Maximum

Dec 2021

248.68M

Average

290.58M

Median

Sep 2022

Cash from Financing (TTM) Benchmarks